Please find attached intimation regarding appointment of Secretarial Auditors.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pharmaids Pharmaceuticals has informed BSE that its shareholders approved the appointment of CS Kashinath Sahu (sole proprietor of M/s Kashinath Sahu & Co, Practicing Company Secretaries) as the company's Secretarial Auditor at the 36th AGM held on September 23, 2025. The appointment is for a five-year term covering FY 2025-26 through FY 2029-30. The Board of Directors had earlier recommended this appointment at its meeting on August 21, 2025. The appointed auditor holds FCS 4790 and CoP 4807 credentials with over 29 years of post-qualification experience.
This is a routine regulatory disclosure required under SEBI Listing Regulations and is unlikely to have any material impact on the stock price. It simply confirms a standard governance appointment approved by shareholders.